Myriad Genetics, Inc. (MYGN) CEO Paul Diaz on Q2 2022 Results - Earnings Call Transcript [Seeking Alpha]
Myriad Genetics, Inc. (MYGN)
Last myriad genetics, inc. earnings: 2/6 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
myriad.com/news-center/investor-information
Company Research
Source: Seeking Alpha
Myriad Genetics, Inc. (NASDAQ:MYGNCompany ParticipantsFoster Harris - IRPaul Diaz - CEO, President & DirectorNicole Lambert - COOBryan Riggsbee - EVP, CFO & TreasurerConference Call ParticipantsKyle Boucher - Cowen and CompanyJack Meehan - Nephron ResearchOperatorGreetings, and welcome to the Myriad Genetics Second Quarter 2022 Financial Earnings Conference Call. [Operator Instructions]. As a reminder, this conference is being recorded today, Thursday, August 4, 2022.I would now like to turn the conference over to Foster Harris. Please go ahead.Thank you. Good afternoon, and welcome to the Myriad Genetics' Second Quarter 2022 Earnings Call. On the call, we will review the financial results we released today and afterwards, we'll host a Q&A session.Our quarterly earnings release was issued this morning on Form 8-K and can be found on our website at investor.myriad.com. I'm Foster Harris, Senior Associate of Investor Relations. On the call with me today are Paul Diaz, our President and
Show less
Read more
Impact Snapshot
Event Time:
MYGN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MYGN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MYGN alerts
High impacting Myriad Genetics, Inc. news events
Weekly update
A roundup of the hottest topics
MYGN
News
- Myriad Genetics (MYGN) Wins Foundational Patent for MRD Assay [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority Date [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics Announces Foundational Patent Granted for Molecular Residual Disease (MRD) with Early Priority DateGlobeNewswire
- Myriad Genetics Announces Patent Granted for SneakPeek® Snap Device [Yahoo! Finance]Yahoo! Finance
- Myriad Genetics Announces Patent Granted for SneakPeek® Snap DeviceGlobeNewswire
MYGN
Earnings
- 2/27/24 - Beat
MYGN
Sec Filings
- 3/27/24 - Form 4
- 3/25/24 - Form 4
- 3/25/24 - Form 4
- MYGN's page on the SEC website